Assembly Biosciences Inc expected to post a loss of 66 cents a share - Earnings Preview

Assembly Biosciences

30/07/2021 14:58

* Assembly Biosciences Inc  ASMB.OQ   ASMB.O  is expected
to show a fall in quarterly revenue when it reports results on
August 3 (estimated). 
* The South San Francisco, California-based company is expected
to report   a 96.2% decrease in revenue to $1.507 million from
$39.38 million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Assembly Biosciences
Inc is for a loss of 66 cents per share. For the same quarter
last year, the company reported earnings of 19 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Assembly
Biosciences Inc is $13​, about 73.3% above​ its last closing
price of $3.47. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.78       -0.79      -0.69     Beat    12.2
 Dec. 31 2020  -0.90       -0.90      -0.96     Missed  -6.2
 Sep. 30 2020  -0.73       -0.75      -0.09     Beat    88​
 Jun. 30 2020  0.24        -0.03      0.19      Beat    733.3
 Mar.          -1.00​      -0.98      -0.76     Beat    22.3​
 31​ 2020​                                              
 Dec. 31 2019  -0.98       -1.01      -0.99     Beat    1.7​
 Sep. 30 2019  -0.91       -0.93      -0.96     Missed  -3.2
 Jun. 30 2019  -1.13       -1.15      -0.72     Beat    37.3
 This summary was machine generated July 30 at 13:58 GMT.  All
figures in US dollars unless otherwise stated